HPV nonavalent vaccine (types 6,11,16,18,31,33,45,52,58) produced in E. coli
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HPV nonavalent vaccine (types 6,11,16,18,31,33,45,52,58) produced in E. coli, covering 2023-06-15 to 2023-06-15. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age [Phase 3]